Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Qiagen ( (QGEN) ) has issued an update.
Qiagen N.V. has announced a change in its total voting rights, now amounting to 217,684,861, effective from April 7, 2025. This adjustment reflects a capital measure under Article 41 of the WpHG, which could influence shareholder dynamics and corporate governance, potentially impacting investor relations and market perception.
More about Qiagen
Qiagen N.V. is a Netherlands-based company operating in the biotechnology industry. It specializes in providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is listed on various stock exchanges including Frankfurt, NYSE, and SIX, and focuses on enhancing healthcare through its innovative solutions.
YTD Price Performance: -12.83%
Average Trading Volume: 1,318,698
Technical Sentiment Signal: Strong Buy
Current Market Cap: $8.71B
For a thorough assessment of QGEN stock, go to TipRanks’ Stock Analysis page.